Resection of invasive pulmonary aspergillosis in immunocompromised patients

Annals of Surgical Oncology

Volumn 7, Issue 4, 2000, Pages 312-317

  Pidhorecky, Ihor ^a,b   Urschel, John ^a   Anderson, Timothy ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Invasive pulmonary aspergillosis; Surgery

Indexed keywords

ANTIFUNGAL AGENT; CYTOTOXIC AGENT;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; COUGHING; FEMALE; FEVER; HEMOPTYSIS; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; LUNG ASPERGILLOSIS; MALE; NEPHRECTOMY; SCHOOL CHILD; THORAX SURGERY;

EID: 0034070754     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-000-0312-6     Document Type: Article

References (26)

1. White DA, Santamauro JT. Pulmonary infections in immunocompromised patients. Curr Opin Pulm Med 1995;1:202-8.
2. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996;23:608-15.
3. Kahn FW, Jones JM, Enland DM. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. Am J Clin Pathol 1986;86:518-23.
4. von Eiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M, van de Loo J. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995;62:341-7.
5. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26:781-805.
6. Hinson KFW, Moon AJ, Plummer NS. Bronchopulmonary aspergillosis: review and report of eight cases. Thorax 1952;7:317-33.
7. Albelda SM, Talbot GH, Gerson SL. Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med 1985;79:57-64.
8. Pagano L, Ricci P, Nosari A. Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in hematological complete remission: a retrospective study and review of literature. Br J Haematol 1995;89: 500-5.
9. Gerson SI, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Casileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984;100:345-51.
10. Robinson LA, Reed EC, Galbraith TA, Alonso A, Moulton AL, Fleming WH. Pulmonary resection for invasive aspergillus infections in immunocompromised patients. J Thorac Cardiovasc Surg 1995;109:1182-97.
11. Baron O, Guillaume B, Moreau P, et al. Aggressive surgical management in localized pulmonary mycotic and nonmycotic infections for neutropenic patients with acute leukemia: report of eighteen cases. J Thorac Cardiovasc Surg 1998;115:63-9.
12. Reichenberger F, Habicht J, Kaim A, et al. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases. Am J Respir Crit Care Med 1998;158:885-90.
13. Caillot D, Casasnovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997;15:139-47.
14. Kuhlman JE, Fishman EK, Burch PA, Karp JE, Zerhouni EA, Siegelman SS. CT of invasive pulmonary aspergillosis. AJR 1988; 150:1015-20.
15. Hruban RH, Meziane MA, Zerhouni EA, Wheeler PS, Dumler JS, Hutchins GM. Radiologic-pathologic correlation of the CT halo sign in invasive pulmonary aspergillosis. J Comput Assist Tomogr 1987;11:534-6.
16. Robertson MJ, Larson RA. Recurrent fungal pneumonias in patients with acute leukemia undergoing multiple courses of intensive chemotherapy. Am J Med 1988;87:233-9.
17. Liles WC, Huang JE, van Burik JA, Bowden RA, Da;e DC. Granulocyte colony-stimulating factor administered in vivo augments neutrophil activity against opportunistic fungal pathogens. J Infect Dis 1997;175:1012-5.
18. Denning DW, Marinus A, Cohen J, et al. An EORTC multicentre prospective survey of invasive aspergillosis in haematologic patients: diagnosis and therapeutic outcome: EORTC Invasive Fungal Infections Cooperative Group. J Infect 1998;37:173-80.
19. Moreau P, Jahar JR, Milpied N, et al. Localized invasive pulmonary aspergillosis in patients with neutropenia. Cancer 1993;72: 3223-6.
20. Bernard A, Caillot D, Couaillier JF, Casasnovas O, Guy H, Favre JP. Surgical management of invasive pulmonary aspergillosis in neutropenic patients. Ann Thorac Surg 1997;64:1441-7.
21. Salerno CT, Ouyang DW, Pederson TS, et al. Surgical therapy for pulmonary aspergillosis in immunocompromised patients. Ann Thorac Surg 1998;65:1415-9.
22. Pagano L, Ricci P, Tonso A, et al. Mucormycosis in patients with haematological malignancies: a retrospective study of 37 cases. Br J Haematol 1997;99:331-6.
23. Tedder M, Spratt JA, Anstadt MP, Hedge SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 1994;57:1044-50.
24. Wingard JR, Mellits ED, Sostrin MB, et al. Interstitial pneumonitis after allogeneic bone marrow transplantation: nine-year experience at a single institution. Medicine (Baltimore) 1988;67:175-86.
25. Husni RN, Gordon SM, Longworth DL, et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis 1998;26:753-5.
26. Peterson PK, McGlave P, Ramsay NKC. A prospective study of infectious diseases following bone marrow transplantation: emergence of aspergillus and cytomegalovirus as the major causes of mortality. Infect Control 1983;4:81-9.